Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP444657.RAlTbCKmPCw58Hag1hqGkG8heKl-GVgw9iFV5nQ_tNFfY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP444657.RAlTbCKmPCw58Hag1hqGkG8heKl-GVgw9iFV5nQ_tNFfY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP444657.RAlTbCKmPCw58Hag1hqGkG8heKl-GVgw9iFV5nQ_tNFfY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP444657.RAlTbCKmPCw58Hag1hqGkG8heKl-GVgw9iFV5nQ_tNFfY130_provenance.
- NP444657.RAlTbCKmPCw58Hag1hqGkG8heKl-GVgw9iFV5nQ_tNFfY130_assertion description "[Valproic acid, trichostatin and their combination with hemin (all three FDA-approved drugs) preferentially increase gamma-globin chain synthesis and may be helpful for the treatment of hemoglobinopathies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP444657.RAlTbCKmPCw58Hag1hqGkG8heKl-GVgw9iFV5nQ_tNFfY130_provenance.
- NP444657.RAlTbCKmPCw58Hag1hqGkG8heKl-GVgw9iFV5nQ_tNFfY130_assertion evidence source_evidence_literature NP444657.RAlTbCKmPCw58Hag1hqGkG8heKl-GVgw9iFV5nQ_tNFfY130_provenance.
- NP444657.RAlTbCKmPCw58Hag1hqGkG8heKl-GVgw9iFV5nQ_tNFfY130_assertion SIO_000772 11454524 NP444657.RAlTbCKmPCw58Hag1hqGkG8heKl-GVgw9iFV5nQ_tNFfY130_provenance.
- NP444657.RAlTbCKmPCw58Hag1hqGkG8heKl-GVgw9iFV5nQ_tNFfY130_assertion wasDerivedFrom befree-20150227 NP444657.RAlTbCKmPCw58Hag1hqGkG8heKl-GVgw9iFV5nQ_tNFfY130_provenance.
- NP444657.RAlTbCKmPCw58Hag1hqGkG8heKl-GVgw9iFV5nQ_tNFfY130_assertion wasGeneratedBy ECO_0000203 NP444657.RAlTbCKmPCw58Hag1hqGkG8heKl-GVgw9iFV5nQ_tNFfY130_provenance.
- befree-20150227 importedOn "2015-02-27" NP444657.RAlTbCKmPCw58Hag1hqGkG8heKl-GVgw9iFV5nQ_tNFfY130_provenance.